Neo-antigen specific cancer vaccines for acute lymphoblastic leukemia—challenges, opportunities, and future directions
Abstract Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy, with standard treatment consisting of intensive chemotherapy and corticosteroids. While curative in most cases, this regimen leads to significant toxicity and long-term sequelae. Recent advancements in cancer immuno...
Saved in:
| Main Authors: | Victoria Bloch Blytt Sandstad, Signe Modvig, Morten Orebo Holmström |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-06-01
|
| Series: | Cancer Immunology, Immunotherapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s00262-025-04107-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overcoming Antigen Escape and T-Cell Exhaustion in CAR-T Therapy for Leukemia
by: Elżbieta Bartoszewska, et al.
Published: (2024-09-01) -
Impact of Chemotherapy on Vaccine Immunogenicity and Revaccination Response of Acute Lymphoblastic Leukemia—A Systematic Review and Meta-Analysis
by: Yuyuan Zeng, et al.
Published: (2025-06-01) -
Surveillance and expected outcome of acute lymphoblastic leukemia in children and adolescents: An experience from Eastern India
by: Ashis Mukhopadhyay, et al.
Published: (2013-01-01) -
Immunophenotypic features of bone marrow tumor cell in Burkitt lymphoma/leukemia: B-lineage acute lymphoblastic leukemia diagnostics opportunities
by: I. A. Demina, et al.
Published: (2017-04-01) -
Hepatic Dysfunction during Induction Chemotherapy in Children with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma and Its Effects on Subsequent Therapy and Outcome
by: Nalla Anuraag Reddy, et al.
Published: (2024-04-01)